Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
posted on
Mar 26, 2020 01:34PM
Fair enough, however I would think that all companies would use the word "may" in News Releases while describing a possible MOA and effectiveness of their drug, until that is, they are clinically proven and receive FDA approval?